You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

293 Results
Drug
Other Name(s): Zytiga®
Aug 2024
Drug
Other Name(s): Caprelsa®
Aug 2023
Drug
Other Name(s): Zelboraf ®
Aug 2023
Drug
Other Name(s): Inlyta®
Apr 2024
Drug
Other Name(s): Erivedge®
Oct 2023
Drug
Other Name(s): Giotrif®
Apr 2024
Drug
Other Name(s): Venclexta®
Aug 2025
Drug
Other Name(s): Alecensaro®
Sep 2025
Drug
Other Name(s): Agrylin®
Apr 2024
Drug
Other Name(s): Tecentriq™
Jul 2025
Regimen
Intent: Palliative, Curative
Funding:
New Drug Funding Program
    Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma
May 2019
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Nov 2019

Pages